AKT1 and early-onset autosomal dominant Alzheimer disease: In a mouse model of Alzheimer’s disease, Se supplementation promoted hippocampal neurogenesis through the PI3K/AKT/GSK-3β/Wnt signaling pathway (Zheng et al., 2017).